Apollomics Inc. (APLM)
Nasdaq: APLM · Pharmaceutical Preparations · Foster City, CA · filing with the SEC since 2022
Income statement, as filed
In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.The Form 20-F filed Apr 24, 2026 for the period ended Dec 31, 2025 is not in EDGAR's company facts yet; its figures here are that filing's own, read from the SEC's financial statement data sets.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period ending | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
| Report filed | Apr 24, 2026 | Apr 3, 2025 | Mar 28, 2024 | Apr 28, 2023 | · | · |
| Revenue | 8,500 | 0 | 0 | 0 | 0 | 0 |
| Research and development | 5,531 | 24,566 | 34,193 | 35,457 | 35,568 | 31,441 |
| General and administrative | 12,442 | 17,768 | 20,641 | 9,947 | 15,291 | 11,043 |
| Operating income | · | · | · | 976 | · | · |
| Finance costs | 65 | 179 | 150 | 93 | 83 | 72 |
| Interest income | · | 480 | 753 | 431 | 467 | 330 |
| Other gains and losses | · | · | · | -829 | 36 | 144 |
| Income before income taxes | -10,936 | -53,599 | -172,591 | -240,810 | -94,796 | -74,905 |
| Income tax expense | 3 | 259 | 10 | 1 | 1 | -85 |
| Net income | -10,939 | -53,858 | -172,601 | -240,811 | -94,797 | -74,820 |
| Earnings per share, basic | -7.57 | -52.80 | -231.99r | -844.95r | -337.00rb | -21.00b |
| Earnings per share, diluted | -7.57 | -52.80 | -231.99r | -844.95r | -337.00rb | -21.00b |
| Weighted average shares, basic | · | 1,020,000 | 744,000r | 285,000r | 281,070rb | 3,614,800b |
| Weighted average shares, diluted | · | 1,020,000 | 744,000r | 285,000r | 281,070rb | 3,614,800b |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-100 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
ifrs-full:RevenueFromContractsWithCustomers
ifrs-full:RevenueResearch and development spent on inventing what it sells next
ifrs-full:ResearchAndDevelopmentExpenseGeneral and administrative the cost of running the company itself
ifrs-full:AdministrativeExpenseOperating income profit from running the business, before interest and tax
ifrs-full:ProfitLossFromOperatingActivitiesFinance costs what its borrowing cost
ifrs-full:FinanceCostsInterest income what its cash and investments earned
ifrs-full:RevenueFromInterestOther gains and losses gains and costs outside the business
ifrs-full:OtherGainsLossesIncome before income taxes profit before tax
ifrs-full:ProfitLossBeforeTaxIncome tax expense tax charged on the period's profit
ifrs-full:IncomeTaxExpenseContinuingOperationsNet income the whole group's profit, minority holders' share included
ifrs-full:ProfitLossEarnings per share, basic net income per share outstanding
ifrs-full:BasicEarningsLossPerShareEarnings per share, diluted net income per share, counting every share that could be issued
ifrs-full:DilutedEarningsLossPerShareWeighted average shares, basic the average count of shares outstanding
ifrs-full:WeightedAverageSharesWeighted average shares, diluted the average count with every share that could be issued
ifrs-full:AdjustedWeightedAverageShares